Background: Despite the large burden medication-related morbidity and mortality places on the Australian health care system, there is little known about the extent of this problem in a women's health (obstetric and gynecology) setting. Objective: Determine the frequency and nature of medication-related problems (MRPs) occurring in a women's health unit (WHU) of an Australian teaching hospital. Methods: A prospective audit of consecutive cases of patients treated in the WHU at a tertiary-level teaching hospital was undertaken by a clinical pharmacist over a 5-week period. Data collected included the following: patient characteristics, type of MRP (using a modified version of the Hepler-Strand classification system), medication involved (according to the World Health Organisation Anatomical Therapeutic Chemical classification system), and clinical significance (using a 2-level severity index). Results: A total of 454 potential MRPs were identified over the 5-week period among 241 patients. A total of 39 MRPs (8.6%) identified were deemed to be of moderate/high clinical significance. The highest number of MRPs (221; 49%) was identified among women admitted following a cesarean delivery, with 83 of 85 women in this group experiencing at least 1 MRP. Additional factors associated with an increased likelihood of patients experiencing a MRP included increased age, length of hospital stay, and number of regular medications taken prior to and during admission (P < 0.05). Conclusion: The widespread nature of identified MRPs in this setting suggests that various approaches to minimizing these problems and mitigating the associated burden on the health care system are warranted.
Introduction
An Australian landmark study undertaken almost 2 decades ago reported that 16.6% of admissions to hospitals were associated with an iatrogenic adverse event, with medication-related adverse events being large contributors to this figure. 1 Such medication-related adverse events are commonly delineated in terms of a framework proposed by Hepler and Strand, 2 which defined a medication-related problem (MRP) as "an event or circumstance involving drug treatment that actually or potentially interferes with the patient experiencing an optimum outcome of medical care." 2(p 535) Although MRP prevalence rates vary significantly across different populations and different studies, likely owing to differing study designs and the lack of a universal definition of MRPs, there remains a clear consensus from all studies that MRPs are not only common but also of significant concern to the health care system. [3] [4] [5] A recognized approach to counteracting MRPs and reducing their associated negative burden has been the expanded role of ward-based clinical pharmacy services. 6 Studies have demonstrated that increased staffing levels for clinical pharmacists and pharmacist-provided admission histories were associated with a statistically significant reduction in medication errors and, subsequently, patient morbidity and mortality. 5, [7] [8] [9] A particularly unique challenge within the women's health setting is that of medication use during pregnancy and lactation. Prescribing medications to women during pregnancy and lactation is often a complex multifactorial scenario, with the need to balance the associated benefits and risks to both the mother and child. 10 Furthermore, the numerous physiological changes that occur during pregnancy can alter medication pharmacokinetics. 11 In addition, obstetric patients are certainly not exempt from experiencing conditions that may require medication therapy, with chronic health conditions, obstetric-related conditions, and complications arising in labor and delivery each affecting an estimated proportion of between 30% and 40% of obstetric patients each year. 12 Further to this, medication use appears to be almost ubiquitous among pregnant women, with Australian studies reporting that up to 97% of women use at least 1 medication (nonprescription medications more commonly used than prescription medications); 26.5% of women were using at least 1 prescribed medication during pregnancy. 13, 14 Few studies have investigated the nature and prevalence of MRPs occurring within a women's health setting. [15] [16] [17] [18] [19] [20] Three previous studies have focused on the evaluation of self-reporting error databases, [17] [18] [19] and although these reports may be useful in highlighting examples of medication errors, they are unable to determine the true frequency with which they occur. An additional 3 studies have focused on evaluating medication errors associated at the point of medication orders (eg, point of prescribing/dispensing), 15, 16, 20 demonstrating variability in the extent to which errors occur, with errors ranging from 0.4/100 orders 20 up to 4.2/100 orders. 16 Notably, because none of these previous studies involved the identification of MRPs following the completion of a detailed pharmacist-provided medication history and clinical evaluation, they are likely to represent an underestimate of the true number of MRPs. Therefore, the aim of this study was to examine the frequency and nature of MRPs occurring in an obstetrics and gynecology hospital inpatient setting.
Methods

Ethics approval was obtained from the University of South Australia and the Lyell McEwin Hospital (LMH)/Queen Elizabeth Hospital/Modbury Hospital Human Research and Ethics Committees.
A prospective clinical audit of consecutive cases of patients treated in the women's health unit (WHU) at the LMH was undertaken over a 5-week study period in June and July 2013. The LMH is a tertiary-level public teaching hospital with a 39-bed WHU and is currently the second largest provider of obstetric services in South Australia (SA), accounting for 15.6% of hospital births in SA in 2010. 12 The model of care provided at the LMH differs somewhat from other maternity units in SA. Women having a vaginal delivery give birth in the labor ward, and if there are no complications with the mother or baby, they are discharged as soon as 6 hours after delivery. Midwives then undertake a series of home visits to ensure that the mother and baby are doing well. Therefore, the clinical case-mix of obstetric patients admitted to the WHU mainly comprises the more complicated vaginal deliveries in addition to cesarean deliveries and antenatal patients. Moreover, some women with uncomplicated vaginal deliveries are admitted to the WHU if the labor ward is over capacity or in the case that the neonate requires observation or treatment in the Special Care Nursery.
During the study period, the WHU was serviced by a ward-based clinical pharmacist during the hours of 9 am to 1 pm on Mondays to Fridays. As part of routine clinical care, the clinical pharmacist was responsible for undertaking a process of medication reconciliation for each obstetric/ gynecology patient admitted to the ward. Medication reconciliation is defined as the formal process of obtaining and verifying a complete and accurate list of a patient's current medications, comparing the medications the patient has actually been prescribed with what they should be prescribed, and discussing any discrepancies with the prescriber. 21 In addition, medication chart reviews were undertaken for each patient on first contact with the pharmacy service and were repeated on subsequent days if time permitted. Any MRPs considered by the clinical pharmacist to require urgent action were brought to the attention of the resident medical officer on the ward immediately. Other less-urgent issues were recorded, along with recommendations, on a separate report as they were identified and discussed with the resident medical officer at the end of the clinical pharmacist's shift. Patients in whom medication reconciliation was not possible (ie, interpreter unavailable, patient discharged prior to pharmacy review) were not included.
All MRPs identified by the clinical pharmacist were recorded using a purpose-built data collection instrument. Data were then entered into a spreadsheet and included data on type of patient (cesarean delivery, vaginal delivery, antenatal, or gynecology), the number of regular medications taken prior to admission and during hospital stay, and length of hospital stay. The type of MRP was classified based on a modified version of the Hepler-Strand classification system. This system is based on 8 fundamental classes of MRPs and although first published some 23 years ago, is still widely used in studies internationally and serves to facilitate a greater understanding surrounding the circumstances in which various MRPs might develop. 22 Medications involved in MRPs were classified according to the World Health Organisation Anatomical Therapeutic Chemical classification system. For simplicity, the clinical significance of each MRP was classified according to a modified version of the 3-level scale originally published by Cornish et al, 23 which originally classified MRPs according to whether they had low, moderate, or severe potential to cause patient harm. We collapsed the 3 levels into 2 levels, with clinical significance classified either as being of low potential to result in patient deterioration or discomfort (level 1) or of moderate or severe potential to result in patient deterioration or discomfort (level 2). The clinical significance was initially assessed by the pharmacist recording the MRP and was subsequently discussed and reviewed by the remaining study authors, with consultation and review by a senior medical representative within the hospital. Interrater agreement was not evaluated between those assessing the clinical significance of each MRP. Medication-related discrepancies deemed not to be of clinical significance prior to commencing the study (ie, the omission of pregnancy multivitamins in a patient who had taken them prior to admission) were not recorded as MRPs.
Descriptive statistics were used to describe patient characteristics and the frequency and nature of identified MRPs. Nonparametric analyses were undertaken, with multiple independent samples compared using a Kruskal-Wallis 1-way analysis of variance (reporting adjusted significance using the Bonferroni correction) and 2 groups compared using a Mann-Whitney U Test. To compare categorical data, a χ 2 test was undertaken if values in each cell were more than or equal to 5. In other cases, a Fisher's exact test was performed. Binary logistic regressions were used to calculate odds ratios (ORs) with 95% CIs for particular variables. Statistical analyses were undertaken using Statistical Package for the Social Sciences (SPSS, Chicago, IL) version 22.0. Statistical significance was defined as a 2-sided P value of <0.05.
Results
Data from a total of 241 patients were included in the study, including 32 (13%) antenatal, 85 (35%) cesarean delivery, 88 (37%) vaginal delivery, and 36 (15%) gynecology patients. Of the 32 antenatal patients, 10 eventually proceeded to parturition during their hospital stay; 7 had a cesarean section and 3 had a vaginal delivery. Significant differences were evidence across the 4 patient groups in relation to age, number of regular medications taken prior to and during admission, obesity, and length of hospital stay (Table 1) .
A total of 454 discrete MRPs were identified. The highest number of MRPs (221; 49%) was identified among women admitted following a cesarean delivery, with 83 of 
Number of chart reviews performed, median (range) ). d Number of regular medications charted as an inpatient was recorded at the point of initial review and updated if noted during a chart review that additional regular medicines were charted. 85 women in this group experiencing at least 1 MRP (Table  1) . Among postnatal women, those with a normal vaginal delivery were significantly less likely to experience a MRP than those with a cesarean delivery (OR = 0.06; 95% CI = 0.02-0.28). Additional factors associated with an increased likelihood of patients experiencing a MRP included increased age, length of hospital stay, and number of regular medications taken prior to and during admission ( Table 2) . Within the obstetric cohort, advanced maternal age (>35 years) was associated with a significantly increased likelihood of experiencing a MRP (OR = 7.75; 95% CI = 1.30-infinity), whereas obesity (defined as body mass index > 30 kg/m 2 ) was not (OR = 1.71; 95% CI = 0.75-3.90).
The types of MRPs identified are presented in Table 3 , which includes an example of each MRP category. When classified according to medication type, the most common therapeutic group implicated in MRPs was alimentary tract and metabolism, mainly aperients and vitamins (32%; Figure 1 ). Medications for the nervous system, largely analgesics and antidepressants, were also a large contributor to MRPs in the study, accounting for 30% of all MRPs. A total of 39 (8.6%) of all MRPs were considered to be of moderate to high clinical significance (classified as level 2 MRPs). Despite being associated with the highest number of total MRPs, cesarean delivery was associated with the lowest proportion of level 2 MRPs, although this was not statistically significant (P = 0.86; Table 1 ). A total of 136 (30%) MRPs were identified in the process of completing medication reconciliation, and the remaining 318 (70%) were identified while undertaking daily medication chart reviews. A higher number of daily medication chart reviews was associated with the identification of at least 1 MRP, as compared with no MRP (P = 0.003).
A total of 92 hours was spent on the ward by the clinical pharmacist over the 5-week period. The 241 patients in the study had a total length of stay of 941 days, with 0.44 level-1 MRPs and 0.041 level-2 MRPs identified per patient day.
Discussion
This study suggests that MRPs are prevalent in the area of women's health, with an average of 0.482 MRPs identified per patient day, highlighting the importance of clinical pharmacy services in identifying, managing, and preventing MRPs. With a paucity of existing data available on MRPs, the results of this study are important in highlighting the types of MRPs and medications likely to be involved in MRPs in this setting. Although the majority of issues identified were of relatively modest clinical significance, the sheer frequency of some of these MRPs is suggestive of possible system problems inherent in day-to-day practices on the unit, potentially improved via simple systems changes.
Few studies have investigated the nature and prevalence of MRPs occurring within a women's health setting, with none undertaken in an Australian setting. A number of previous studies have focused on medication errors identified by error reporting systems or retrospective chart reviews. [17] [18] [19] Although such self-reported notifications are useful in providing potential insight into the nature of MRPs in this setting, they are likely to result in an underestimation of the total number of medication errors. Subsequent prospective studies also have their own limitations, such as focusing on medication errors associated with prescribed orders only, rather than the detailed range of MRPs explored in this present study. 15, 16, 20 Therefore, although the incidence of MRPs may appear approximately 10-fold higher in our present study compared with that reported previously (1.88/ woman vs 0.20/woman 16 ) , this is likely a reflection of the methodological differences between studies. For example, the process of medication reconciliation as undertaken by the pharmacist proved crucial to the identification of many issues identified in our study. Previous research has reviewed the value of medication reconciliation in terms of reducing the incidence of both medication errors and subsequent adverse drug reactionss. 24 In the present study, medication reconciliation assisted in the identification of 136 MRPs (including 6 level 2 MRPs) over the 5-week period-30% of the overall total. A further benefit of a detailed medication history is in identifying regular medications that have not been charted during hospital admission; this accounted for 112 (28%) of the MRPs identified in obstetric patients. Many of these involved the use of medications in the management of identified vitamin D deficiency (37%), asthma (35%), and depression (11%). It is important to be aware of a patient's medical and medication history because these can have an impact on clinical care, and the continued use of regular medications (eg, antiepileptics) may be vital in ensuring adequate continued management of certain conditions. Furthermore, the charting of regular medications provides opportunities to discuss and support their use in the clinical setting (eg, use of medications while breastfeeding). The identification of factors associated with an increased risk of experiencing a MRP is useful to determine which patients are at most risk of experiencing a MRP; therefore, this can be used as a guide to prioritize work load on the ward. Factors associated with a significantly increased risk of experiencing a MRP included increased length of hospital stay, number of regular medications taken prior to and during admission, age, and cesarean delivery. A number of these factors are likely to be closely correlated. For example, advancing age, which is more common among gynecology patients than obstetric patients, is often associated with an increased occurrence of comorbidities and subsequent medication use. In this study, within the obstetric setting, advanced maternal age (>35 years) was associated with a significantly increased likelihood of experiencing a MRP. This is probably not surprising given that advanced maternal age has been associated with an increased risk of preexisting medical conditions (eg, hypertension), obstetric complications (eg, gestational diabetes), and adverse labor and birth outcomes (eg, cesarean section). 25 Like advanced maternal age, obesity also increases the risk of numerous pregnancy-related complications. 26 However, despite obese women being more likely to have undergone cesarean section and be older compared with nonobese women, no difference was observed in relation to the presence of MRPs.
Of note, although a number of risk factors were identified, the presence of a clinically significant level 2 MRP could not clearly be predicted based on any specific patient characteristic. This makes it difficult when prioritizing clinical pharmacy service delivery because only examining MRPs among patients considered to be at high risk could lead to missing clinically significant MRPs among other patients.
In this study, cesarean section patients experienced significantly more MRPs (P < 0.001) and were significantly more likely to experience at least 1 MRP compared with those who had vaginal deliveries (OR = 0.06; 95% CI = 0.02-0.28), although they were not more likely to experience a level-2 MRP. In the South Australian public health system, patients are usually only eligible for an elective cesarean section if there is a medical reason (eg, hypertension, antepartum hemorrhage, or multiple pregnancy) for this to occur, and emergency cesarean sections are performed for similar reasons in addition to fetal distress and failure to progress during labor. 12 Furthermore, a cesarean procedure is associated with increased maternal morbidity because of the invasive nature of the procedure, with complications that include increased risk of thrombosis and postpartum hemorrhage. 27 This increased complexity of cesarean section patients was evident in the present study in view of the significantly longer hospital stay, number of medications taken prior to admission, and greater number of medications charted for cesarean patients as compared with those with vaginal deliveries. However, it should be noted that the vaginal delivery patient group in the present study is not necessarily representative of all vaginal births in the facility and may in fact be skewed toward more medically complex cases, given the model of care implemented on the ward, which affects the ability to draw generalizations from these comparisons. This may help explain the similar observed distribution of severity of MRPs among the vaginal and cesarean delivery patients.
This study has a number of limitations. First, MRPs were only assessed within the WHU, not the labor ward. Previous research suggests that these areas are not exempt from MRPs, with 1 study reporting that half of the errors reported in their study occurred here. 18 Second, the generalizability of these results is influenced by the short study period and single-site methodology. Whereas many aspects of clinical care remain constant (ie, senior medical staff, nursing/midwifery staff), much of the ward-based clinical care is undertaken by junior doctors on rotating placements, and therefore, the presence of MRPs could differ according to their varying levels of experience in obstetrics and gynecology. Furthermore, it is possible that the frequency and nature of MRPs identified within this setting may not be reflective of that in other hospitals because of differences in clinical staff, patient characteristics, and/or differing clinical management protocols. Third, the assignment of severity classifications to MRPs was not validated. Although the severities were assigned by an experienced group of clinical pharmacists and reviewed by a senior medical representative within the hospital, interrater agreement was not evaluated. Finally, whereas the utility of a pharmacist in this setting is likely to extend beyond the identification and resolution of MRPs (eg, the provision of information on the safety of medications in pregnancy and breastfeeding as well as discharge counseling), these activities were not systematically recorded or analyzed over the study period. Future research might reasonably include a more formal investigation into the overall value of a clinical pharmacist in this specialized context.
In conclusion, this study demonstrates that MRPs are widespread within a women's health setting. Future research should address whether clinical pharmacy services have the potential to reduce the frequency and significance of MRPs in this setting and whether this leads to improvements in patient health outcomes.
